Inventor · disambiguated record
Itschak Lamensdorf
Also filed as: LAMENSDORF ITSCHAK
13 granted patents·7 pending applications·93 citations·filing 2004–2025
89Inventor score
Top patents by PatentIndex Score
20 records- 0195US9233245B2SPG stimulationBRAINSGATE LTD·Filed 2015·Granted Jan 12, 2016·51 cites·7 claims
- 0283US11426365B2Compositions comprising thymoquinone and omega-3 fatty acidsTRINUTRA LTD·Filed 2018·Granted Aug 30, 2022·2 cites·14 claims
- 0380US8055347B2Stimulation for treating brain events and other conditionsBRAINSGATE LTD·Filed 2006·Granted Nov 8, 2011·23 cites·32 claims
- 0475US10159702B2Synergistic combinations of caffeine, ginkgo biloba and beta-phenylethylamineTRINUTRA LTD·Filed 2017·Granted Dec 25, 2018·2 cites·19 claims
- 0575US8958881B2Neuroprotective electrical stimulationBRAINSGATE LTD·Filed 2013·Granted Feb 17, 2015·7 cites·7 claims
- 0673US8406869B2Post-acute electrical stimulation treatment of adverse cerebrovascular eventsLAMENSDORF ITSCHAK·Filed 2011·Granted Mar 26, 2013·8 cites·10 claims
- 0765US11266701B2Synergistic combinations of caffeine, ginkgo biloba and beta-phenylethylamineTRINUTRA LTD·Filed 2018·Granted Mar 8, 2022·0 cites·17 claims
- 0865US2023102251A1Compositions comprising thymoquinone and omega-3 fatty acidsTRINUTRA LTD·Filed 2022·Application pending·0 cites
- 0960US8969417B2Pharmaceutical compositions for treatment of Parkinsons diseaseLAMENSDORF ITSCHAK·Filed 2009·Granted Mar 3, 2015·0 cites·5 claims
- 1059US2025387444A1Fixed dose combination of cannabinoids and medical mushrooms for prevention and treatment of cancer, inflammatory or immune-mediated inflammatory diseasesALVIT LCS PHARMA LTD·Filed 2025·Application pending·0 cites
- 1155US2023134563A1Sublingual cannabinoid compositionsALVIT LCS PHARMA LTD·Filed 2022·Application pending·0 cites
- 1250US2006142227A1Amphiphylic peptide-PNA conjugates for the delivery of PNA through the blood brain barrierLAMENSDORF ITSCHAK·Filed 2004·Application pending·0 cites
- 1348US12453750B2Fixed dose combination of cannabinoids and medical mushrooms for prevention and treatment of cancer, inflammatory or immune-mediated inflammatory diseasesALVIT LCS PHARMA LTD·Filed 2020·Granted Oct 28, 2025·0 cites·7 claims
- 1448US2005222009A1Dual phase - PNA conjugates for the delivery of PNA through the blood brain barrierLAMENSDORF ITSCHAK·Filed 2004·Application pending·0 cites
- 1545US2020170994A1Sublingual cannabinoid compositionsSELA YORAM·Filed 2018·Application pending·0 cites
- 1643US10675269B2Compositions comprising melatoninTRINUTRA LTD·Filed 2017·Granted Jun 9, 2020·0 cites·13 claims
- 1741US2009299418A1Concurrent bilateral spg modulationBRAINSGATE LTD·Filed 2005·Application pending·0 cites
- 1840US9259418B2Pharmaceutical compositions for treatment of Parkinson's diseasePHARMATWOB LTD·Filed 2015·Granted Feb 16, 2016·0 cites·5 claims
- 1938US11103458B2Stimulant abuse-deterrent compositions4P PHARMA·Filed 2016·Granted Aug 31, 2021·0 cites·13 claims
- 2038US9943489B2Extended release formulations of rasagiline and uses thereofSELA YORAM·Filed 2011·Granted Apr 17, 2018·0 cites·25 claims
Join the waitlist — get patent alerts
Get an alert when Itschak Lamensdorf files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →